| 2025-12-12 |
详情>>
内部人交易：
Chung Jane共交易2笔
|
| 2025-12-03 |
复牌提示：
2025-12-02 19:50:00 停牌，复牌日期 2025-12-03 09:00:00
|
| 2025-12-01 |
详情>>
股本变动：
变动后总股本851.94万股
变动原因 ▼▲
- 原因：
- a reverse stock split of the Company's outstanding shares of common stock at a ratio of 1-for-10
|
| 2025-12-01 |
详情>>
拆分方案：
每10.0000合并分成1.0000股
|
| 2025-11-06 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-1.71美元,归母净利润-1.44亿美元,同比去年增长6.90%
|
| 2025-08-07 |
详情>>
业绩披露：
2025年中报每股收益-1.04美元,归母净利润-8746.7万美元,同比去年增长17.66%
|
| 2025-05-08 |
详情>>
业绩披露：
2025年一季报每股收益-0.91美元,归母净利润-7596.8万美元,同比去年增长-30.5%
|
| 2025-04-25 |
股东大会：
将于2025-06-06召开股东大会
会议内容 ▼▲
- 1.To elect three Class I directors, each to serve three-year terms through the third annual meeting of shareholders following this meeting and until a successor has been elected and qualified or until earlier resignation or removal.
2.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.
3.To approve, on a non-binding advisory basis, the compensation of our named executive officers as disclosed in the proxy statement for the 2025 Annual Meeting.
4.To approve an amendment to our Restated Certificate of Incorporation to effect a reverse stock split of our outstanding shares of common stock at a ratio of any whole number between 1-for-5 and 1-for-25, with the exact ratio determined by the board of directors in its discretion, subject to the board of directors’ authority to abandon such amendment.
5.In addition, stockholders may be asked to consider and vote upon such other business as may properly come before the meeting or any adjournment or postponement thereof.
|
| 2025-03-13 |
详情>>
业绩披露：
2022年年报每股收益-2.35美元,归母净利润-1.19亿美元,同比去年增长-12.95%
|
| 2025-03-13 |
详情>>
业绩披露：
2024年年报每股收益-2.96美元,归母净利润-2.27亿美元,同比去年增长-112.99%
|
| 2024-11-13 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-2.07美元,归母净利润-1.55亿美元,同比去年增长-12.45%
|
| 2024-08-13 |
详情>>
业绩披露：
2024年中报每股收益-1.49美元,归母净利润-1.06亿美元,同比去年增长-19.93%
|
| 2024-08-13 |
详情>>
业绩披露：
2023年中报每股收益-1.49美元,归母净利润-8857.4万美元,同比去年增长-36.01%
|
| 2024-05-13 |
详情>>
业绩披露：
2024年一季报每股收益-0.95美元,归母净利润-5821.3万美元,同比去年增长-16.31%
|
| 2024-04-26 |
股东大会：
将于2024-06-06召开股东大会
会议内容 ▼▲
- 1.To elect two Class III directors, each to serve three-year terms through the third annual meeting of stockholders following this meeting and until a successor has been elected and qualified or until earlier resignation or removal.
2.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024.
3.To approve, on a non-binding advisory basis, the compensation of our named executive officers as disclosed in the proxy statement for the 2024 Annual Meeting.
4.To approve an amendment to our 2018 Employee Stock Purchase Plan (“ESPP”) to (i) increase the overall limit on the number of shares that may be issued under the ESPP throughout its ten-year term, and (ii) make certain non-substantive clarifying revisions.
|
| 2024-03-25 |
详情>>
业绩披露：
2023年年报每股收益-1.78美元,归母净利润-1.07亿美元,同比去年增长10.41%
|
| 2023-11-13 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-2.3美元,归母净利润-1.38亿美元,同比去年增长-62.93%
|
| 2023-04-28 |
股东大会：
将于2023-06-08召开股东大会
会议内容 ▼▲
- 1.To elect three Class II directors, each to serve three-year terms through the third annual meeting of stockholders following this meeting and until a successor has been elected and qualified or until earlier resignation or removal.
2.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023.
3.To approve, on a non-binding advisory basis, the compensation of our named executive officers as disclosed in the proxy statement for the 2023 Annual Meeting.
4.To approve the amendment and restatement of our amended and restated certificate of incorporation to permit the exculpation of our officers from personal liability for certain breaches of the duty of care.
|
| 2022-04-25 |
股东大会：
将于2022-06-06召开股东大会
会议内容 ▼▲
- 1.To elect four Class I directors, each to serve three-year terms through the third annual meeting of stockholders following this meeting and until a successor has been elected and qualified or until earlier resignation or removal.
2.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022.
3.To approve, on a non-binding advisory basis, the compensation of the company’s named executive officers as disclosed in the proxy statement for the 2022 Annual Meeting.
4.To approve, on a non-binding advisory basis, the frequency of future votes on the compensation of the company’s named executive officers.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-29 |
股东大会：
将于2021-06-03召开股东大会
会议内容 ▼▲
- 1.To elect three Class III directors, each to serve three-year terms through the third annual meeting of stockholders following this meeting and until a successor has been elected and qualified or until earlier resignation or removal.
2.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2021.
|
| 2020-04-24 |
股东大会：
将于2020-06-05召开股东大会
会议内容 ▼▲
- 1.To elect three Class II directors, each to serve three-year terms through the third annual meeting of stockholders following this meeting and until a successor has been elected and qualified or until earlier resignation or removal.
2.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2020.
|
| 2019-04-26 |
股东大会：
将于2019-06-07召开股东大会
会议内容 ▼▲
- 1.To elect two Class I directors, each to serve three-year terms through the third annual meeting of stockholders following this meeting and until a successor has been elected and qualified or until earlier resignation or removal.
2.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2019.
|